Implant Reclassification Required In Many Cases, EU Regulators Agree
This article was originally published in The Gray Sheet
Executive Summary
Vigilance data collected by the Swedish National Board of Health and Welfare show that adverse events are linked to device design problems twice as often as manufacturing problems, the board's device official Bo Hojdefors, reported March 27 at an IBC regulatory conference in London.
You may also be interested in...
EU Medical Devices Directive Review Invites Reclassification Requests
The European Commission is encouraging member states to use Article 13 of the Medical Devices Directive to submit requests for reclassification, rather than reforming the directive itself
EU Medical Devices Directive Review Invites Reclassification Requests
The European Commission is encouraging member states to use Article 13 of the Medical Devices Directive to submit requests for reclassification, rather than reforming the directive itself
Device Type Reclassification Urged As Alternative To EU Implant Proposal
European member states should exercise their option to reclassify specific product types as an alternative to the wholesale reclassification of implants from Class IIb to Class III, EUCOMED maintains.